(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(-0.94%) $83.06
(-1.16%) $1.619
(-0.27%) $2 340.80
(-0.33%) $27.45
(0.63%) $927.90
(-0.14%) $0.933
(-0.14%) $11.01
(-0.21%) $0.799
(0.00%) $92.17
Live Chart Being Loaded With Signals
Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity, a MR-Linac technology; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for advanced image-guided radiation therapy; treatment management solutions; automated and integrated quality assurance solutions; and hardware and software motion management technology...
Stats | |
---|---|
本日の出来高 | 32 188.00 |
平均出来高 | 9 071.00 |
時価総額 | 2.52B |
EPS | $0 ( 2024-03-01 ) |
次の収益日 | ( $0 ) 2024-05-23 |
Last Dividend | $0.117 ( 2023-08-25 ) |
Next Dividend | $0 ( N/A ) |
P/E | 19.59 |
ATR14 | $0.0210 (0.31%) |
Elekta AB (publ) 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Elekta AB (publ) 財務諸表
Annual | 2023 |
収益: | $16.87B |
総利益: | $6.35B (37.64 %) |
EPS: | $2.47 |
FY | 2023 |
収益: | $16.87B |
総利益: | $6.35B (37.64 %) |
EPS: | $2.47 |
FY | 2022 |
収益: | $14.55B |
総利益: | $5.44B (37.37 %) |
EPS: | $3.02 |
FY | 2021 |
収益: | $13.76B |
総利益: | $5.61B (40.76 %) |
EPS: | $3.28 |
Financial Reports:
No articles found.
Elekta AB (publ) Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.118 (N/A) |
$0 (N/A) |
$0.118 (N/A) |
$0 (N/A) |
$0.117 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.305 | 2013-09-04 |
Last Dividend | $0.117 | 2023-08-25 |
Next Dividend | $0 | N/A |
Payout Date | 2023-09-15 | |
Next Payout Date | N/A | |
# dividends | 18 | -- |
Total Paid Out | $1.985 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.83 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 4.91 | |
Div. Directional Score | 8.83 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
SAFRY | Ex Dividend Junior | 2023-05-30 | Annually | 0 | 0.00% | |
FMBL | Ex Dividend Junior | 2023-09-14 | Quarterly | 0 | 0.00% | |
WRTBY | Ex Dividend Knight | 2023-09-12 | Semi-Annually | 0 | 0.00% | |
MCHB | Ex Dividend Knight | 2023-08-09 | Annually | 0 | 0.00% | |
CNAF | Ex Dividend Knight | 2023-08-24 | Quarterly | 0 | 0.00% | |
SONVY | Ex Dividend Knight | 2023-06-14 | Annually | 0 | 0.00% | |
HEGIY | Ex Dividend Knight | 2023-09-15 | Semi-Annually | 0 | 0.00% | |
ANIOY | Ex Dividend Knight | 2023-07-13 | Annually | 0 | 0.00% | |
NODB | Ex Dividend Junior | 2023-10-17 | Quarterly | 0 | 0.00% | |
CUYTY | Ex Dividend Junior | 2023-09-29 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0786 | 1.500 | 8.43 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0466 | 1.200 | 8.45 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.141 | 1.500 | 9.54 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.640 | -1.000 | 3.60 | -3.60 | [0 - 1] |
currentRatioTTM | 1.095 | 0.800 | 9.53 | 7.62 | [1 - 3] |
quickRatioTTM | 0.822 | 0.800 | 9.87 | 7.90 | [0.8 - 2.5] |
cashRatioTTM | 0.181 | 1.500 | -0.104 | -0.156 | [0.2 - 2] |
debtRatioTTM | 0.198 | -1.500 | 6.70 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 6.24 | 1.000 | 8.80 | 8.80 | [3 - 30] |
operatingCashFlowPerShareTTM | 8.21 | 2.00 | 7.26 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 3.98 | 2.00 | 8.01 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.593 | -1.500 | 7.63 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.377 | 1.000 | 7.04 | 7.04 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.129 | 1.000 | 9.41 | 9.41 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.516 | 1.000 | 8.25 | 8.25 | [0.2 - 2] |
assetTurnoverTTM | 0.593 | 0.800 | 9.38 | 7.50 | [0.5 - 2] |
Total Score | 12.75 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 20.00 | 1.000 | 8.08 | 0 | [1 - 100] |
returnOnEquityTTM | 0.141 | 2.50 | 9.70 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 3.98 | 2.00 | 8.67 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.309 | 1.500 | 2.27 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 8.21 | 2.00 | 7.26 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.640 | 1.500 | 3.60 | -3.60 | [0 - 1] |
pegRatioTTM | -0.100 | 1.500 | -4.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.172 | 1.000 | 8.20 | 0 | [0.1 - 0.5] |
Total Score | 4.91 |
Elekta AB (publ)
Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity, a MR-Linac technology; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for advanced image-guided radiation therapy; treatment management solutions; automated and integrated quality assurance solutions; and hardware and software motion management technology. It also provides MOSAIQ Plaza for multidisciplinary cancer care; Elekta Axis Cloud, a managed hosting service; Elekta Studio, an image-guided brachytherapy solution; ImagingRing, a mobile CT scanner; Oncentra Brachy, a smart tool that facilitate repetitive tasks; Venezia applicator that enables the radiation oncologist to treat locally advanced cervical cancer; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; and Geneva, an applicator for cervical cancer treatment. In addition, the company offers Leksell Gamma Knife Icon for personalized radiation treatment; Leksell Gamma Knife Perfexion, a tool for neurosurgeons; Leksell Gamma Knife Lightning for accelerated radiosurgery. Further, it provides neurosurgery products comprising Leksell Vantage Stereotactic System for intracranial neurosurgery; and Leksell Stereotactic System or minimally invasive stereotactic neurosurgery. The company was incorporated in 1972 and is headquartered in Stockholm, Sweden.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。